Consortium wins awards
29 June 2011
The Cystic Fibrosis Gene Therapy Consortium, a collaboration between Imperial and the Universities of Oxford and Edinburgh, had a double success at the Medical Futures Innovation Awards 2011. The consortium, which is coordinated by Professor Eric Alton (NHLI), received the MRC Translational Research Award and Best Therapeutic Innovation (Respiratory) prize. It has developed a new method of delivering DNA into the lungs of cystic fibrosis patients using a virus. The awards recognise groundbreaking innovation by frontline clinicians and scientists that have the potential to transform people’s lives.